Reduced levels of the adenomatous polyposis coli (APC) protein are associated with ceramide-induced apoptosis of colon cancer cells

Journal of Cancer Research and Clinical Oncology

Volumn 130, Issue 12, 2004, Pages 695-703

  Jaiswal, Aruna S ^a   Narayan, Satya ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; C2 ceramide; C2 dihydroceramide; Colon cancer; p21(Waf 1 Cip 1); p53; ZnCl2 APC

Indexed keywords

APC PROTEIN; CERAMIDE; CERAMIDE C2; CYCLIN DEPENDENT KINASE INHIBITOR 1; DIHYDROCERAMIDE C2; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN P53; UNCLASSIFIED DRUG; ZINC CHLORIDE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CHEMOPROPHYLAXIS; COLON CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INDUCTION; PROTEIN STABILITY; WESTERN BLOTTING; WILD TYPE;

ADENOMATOUS POLYPOSIS COLI PROTEIN; APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; CERAMIDES; CHLORIDES; COLONIC NEOPLASMS; GENES, P53; HUMANS; SPHINGOSINE; TUMOR CELLS, CULTURED; ZINC COMPOUNDS;

EID: 12444281773     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-004-0591-6     Document Type: Article

References (54)

1. Ahn EH, Schroeder JJ (2002) Sphingoid bases and ceramide induce apoptosis in HT-29 and HCT-116 human colon cancer cells. Exp Biol Med 227:345-353
2. Ames BN, Gold LS (1998) The causes and prevention of cancer: the role of environment. Biotherapy 11:205-220
3. Berra B, Colombo I, Sottocornola E, Giacosa A (2002) Dietary sphingolipids in colorectal cancer prevention. Eur J Cancer Prev 11:193-197
4. Bienz M (2002) The subcellular destinations of APC proteins. Nat Rev Mol Cell Biol 3:328-338
5. Browne SJ, MacFarlane M, Cohen GM, Paraskeva C (1998) The adenomatous polyposis coli protein and retinoblastoma protein are cleaved early in apoptosis and are potential substrates for caspases. Cell Death Differ 5:206-213
6. Bruce WR, Giacca A, Medline A (2000) Possible mechanisms relating diet and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 9:1271-1279
7. Bunz F, Hwang PM, Torrance C, Waldman T, Zhang Y, Dillehay L, Williams J, Lengauer C, Kinzler KW, Vogelstein B (1999) Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J Clin Invest 104:263-269
8. Chan TA, Morin PJ, Vogelstein B, Kinzler KW (1998) Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc Natl Acad Sci USA 95:681-686
9. Chauvier D, Morjani H, Manfait M (2002) Ceramide involvement in homocamptothecin- and camptothecin-induced cytotoxicity and apoptosis in colon HT29 cells. Int J Oncol 20:855-863
10. Dillehay DL, Webb SK, Schmelz EM, Merrill AH, Jr (1994) Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF1 mice. J Nutr 124:615-620
11. Fearnhead NS, Britton MP, Bodmer WF (2001) The ABC of APC. Hum Mol Genet 10:721-733
12. Gartel AL, Tyner AL (2002) The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 1:639-649
13. Hannun YA (1997) In: Hannun YS (ed) Sphingolipid-mediated signal transduction. Landes Chapman & Hall, Austin, USA
14. Hasegawa S, Sato T, Akazawa H, Okada H, Maeno A, Ito M, Sugitani Y, Shibata H, Miyazaki Ji J, Katsuki M, Yamauchi Y, Yamamura Ki K, Katamine S, Noda T (2002) Apoptosis in neural crest cells by functional loss of APC tumor suppressor gene. Proc Natl Acad Sci USA 99:297-302
15. Hotz MA, Gong J, Traganos F, Darzynkiewicz Z (1994) Flow cytometric detection of apoptosis: comparison of the assays of in situ DNA degradation and chromatin changes. Cytometry 15:237-244
16. Hursting SD (1997) Experimental models of gene-environment interaction for cancer chemoprevention studies. Curr Opin Oncol 9:487-491
17. Jaiswal AS, Bloom LB, Narayan S (2002a) Long-patch base excision repair of apurinic/apyrimidinic site DNA is decreased in mouse embryonic fibroblast cell lines treated with plumbagin: involvement of cyclin-dependent kinase inhibitor p21Waf-1/ Cip-1. Oncogene 21:5912-5922
18. Jaiswal AS, Marlow BP, Gupta N, Narayan S (2002b) Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene 21:8414-8427
19. Jaiswal AS, Narayan S (2004) Zinc stabilizes adenomatous polyposis coli (APC) protein levels and induces cell cycle arrest in colon cancer cells. J Cell Biochem (in press) (DOI 10.1002/ jcb.20193)
20. Kelloff GJ, Boone CW, Steele VE, Crowell JA, Lubet R, Sigman CC (1994) Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials. Cancer Res 54 [Suppl]:2015s-2024s
21. Kishimoto Y, Morisawa T, Hosoda A, Shiota G, Kawasaki H, Hasegawa J (2002) Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane. J Exp Clin Cancer Res 21:203-211
22. Kok JW, Nikolova-Karakashian M, Klappe K, Alexander C, Merrill AH, Jr (1997) Dihydroceramide biology. Structure-specific metabolism and intracellular localization. J Biol Chem 272:21128-21136
23. Kolesnick R (2002) The therapeutic potential of modulating the ceramide/sphingomyelin pathway. J Clin Invest 110:3-8
24. Kolesnick RN, Kronke M (1998) Regulation of ceramide production and apoptosis. Annu Rev Physiol 60:643-665
25. Kolesnick RN, Goni FM, Alonso A (2000) Compartmentalization of ceramide signaling: physical foundations and biological effects. J Cell Physiol 184:285-300
26. Liu MC, Gelmann EP (2002) p53 gene mutations: case study of a clinical marker for solid tumors. Semin Oncol 29:246-257
27. Marnett LJ, DuBois RN (2002) COX-2: a target for colon cancer prevention Annu Rev Pharmacol Toxicol 42:55-80
28. Modrak DE, Rodriguez MD, Goldenberg DM, Lew W, Blumenthal RD (2002) Sphingomyelin enhances chemotherapy efficacy and increases apoptosis in human colonic tumor xenografts. Int J Oncol 20:379-384
29. Morin PJ, Vogelstein B, Kinzler KW (1996) Apoptosis and APC in colorectal tumorigenesis. Proc Natl Acad Sci USA 93:7950-7954
30. Narayan S, Jaiswal, AS (1997) Activation of adenomatous polyposis coli (APC) gene expression by the DNA-alkylating agent N-methyl-N′-nitro-N- nitrosoguanidine requires p53. J Biol Chem 272:30619-30622
31. Obeid LM, Linardic CM, Karolak LA, Hannun YA (1993) Programmed cell death induced by ceramide. Science 259:1769-1771
32. Okazaki T, Bielawska A, Bell RM, Hannun YA (1990) Role of ceramide as a lipid mediator of 1-alpha,25-dihydroxyvitamin DS-induced HL-60 cell differentiation. J Biol Chem 265:15823-15831
33. Oren M, Damalas A, Gottlieb T, Michael D, Taplick J, Leal JF, Maya R, Moas M, Seger R, Taya Y, Ben-Ze'ev A (2002) Regulation of p53: intricate loops and delicate balances. Biochem Pharmacol 64:865-871
34. Oshima M, Taketo MM (2002) COX selectivity and animal models for colon cancer. Curr Pharm Des 8:1021-1034
35. Parodi PW (1997) Fat components as potential anticarcinogenic agents. J Nutr 127:1055-1060
36. Prajapati S, Gaynor RB (2002) Regulation of Ikappa B kinase (IKK) gamma /NEMO function by IKKbeta -mediated phosphorylation. J Biol Chem 277:24331-24339
37. Rezvani M, Liew CC (2000) Role of the adenomatous polyposis coli gene product in human cardiac development and disease. J Biol Chem 275:18470-18475
38. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Edwards BK (2002) SEER Cancer statistics review, 1973-1999. National Cancer Institute, Bethesda, USA
39. Schmelz EM, Dillehay DL, Webb SK, Reiter A, Adams J, Merrill AH, Jr (1996) Sphingomyelin consumption suppresses aberrant colonic crypt foci and increases the proportion of adenomas versus adenocarcinomas in CF1 mice treated with 1,2-dimethylhydrazine: implications for dietary sphingolipids and colon carcinogenesis. Cancer Res 56:4936-4941
40. Schmelz EM, Bushnev AS, Dillehay DL, Liotta DC, Merrill AH, Jr (1997) Suppression of aberrant colonic crypt foci by synthetic sphingomyelins with saturated or unsaturated sphingoid base backbones. Nutr Cancer 28:81-85
41. Schmelz EM, Sullards MC, Dillehay DL, Merrill AH, Jr (2000) Colonic cell proliferation and aberrant crypt foci formation are inhibited by dairy glycosphingolipids in 1, 2-dimethylhydrazine-treated CF1 mice. J Nutr 130:522-527
42. Schmelz EM, Roberts PC, Kustin EM, Lemonnier LA, Sullards MC, Dillehay DL, Merrill AH, Jr (2001) Modulation of intracellular beta-catenin localization and intestinal tumori-genesis in vivo and in vitro by sphingolipids. Cancer Res 61:6723-6729
43. Selzner M, Bielawska A, Morse MA, Rudiger HA, Sindram D, Hannun YA, Clavien PA (2001) Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer. Cancer Res 61:1233-1240
44. Sinha R (2002) An epidemiologic approach to studying heterocyclic amines. Mutat Res 506-507:197-204
45. Slattery ML (2000) Diet, lifestyle, and colon cancer. Semin Gastrointest Dis 11:142-146
46. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM (1995) Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81:801-809
47. van Es JH, Giles RH, Clevers HC (2001) The many faces of the tumor suppressor gene APC. Exp Cell Res 264:126-134
48. Veldman RJ, Klappe K, Hoekstra D, Kok JW (1998) Metabolism and apoptotic properties of elevated ceramide in HT29rev cells. Biochem J 331:563-569
49. Vesper H, Schmelz EM, Nikolova-Karakashian MN, Dillehay DL, Lynch DV, Merrill AH, Jr (1999) Sphingolipids in food and the emerging importance of sphingolipids to nutrition. J Nutr 129:1239-1250
50. Vousden KH, Lu X (2002) Live or let die: the cell's response to p53. Nat Rev Cancer 2:594-604
51. Willett WC (2000) Diet and cancer. Oncologist 5:393-404
52. Yamamoto Y, Gaynor RB (2001) Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest 107:135-142
53. Yamamoto Y, Yin MJ, Lin KM, Gaynor RB (1999) Sulindac inhibits activation of the NF-kappaB pathway. J Biol Chem 274:27307-27314
54. Yu HG, Huang JA, Yang YN, Huang H, Luo HS, Yu JP, Meier JJ, Schrader H, Bastian A, Schmidt WE, Schmitz F (2002) The effects of acetylsalicylic acid on proliferation, apoptosis, and invasion of cyclooxygenase-2 negative colon cancer cells. Eur J Clin Invest 32:838-846